+27 (0)83 440 0793 mark.fyvie@vxpharma.com
Select Page


VX Pharma has 100% acquisition of Syzygy


Syzygy is now under management of VX Pharma. 


Our phase 3 and 4 outpatient trial business in Pretoria, Syzygy, gives Vx Pharma late-phase capabilities as well as unprecedented access to outpatients for inpatient studies through their exclusive strategic alliance with the company’s founders: The Intercare Group.

The Intercare Group operates 15 medical and dental centres around the country, managing the healthcare needs of over 600 000 patients per annum. The group also has two sub-acute hospitals and two day hospitals, where specialists and doctors conduct the following types of day surgery: dental surgery, dermatology, ENT, gastroenterology, general surgery, gynaecology, maxillo-facial surgery, ophthalmology, orthopaedic surgery, periodontics, plastic surgery and urology.

Current Trials Open To Enrollment

  • Insulin Dependent Type 2 Diabetes Mellitus in Elderly
  • Type 2 Diabetes Mellitus and Established Vascular Disease
  • Type 2 Diabetes Mellitus at high vascular risk
  • Mild to Moderate Asthma in Adults
  • Insulin Dependent Type 2 Diabetes Mellitus in Adults
  • New Therapy in Treatment Naive HIV Positive Adults
  • Chronic Obstructive Pulmonary Disease (COPD): Severe to Very Severe COPD Patients
  • Type I Diabetes Mellitus
  • Moderate to Severe Uncontrolled Asthma in Adolescents and Adults
  • Uncomplicated Influenza (Phase1 and Phase3)



Need more information? Send us an enquiry.

    I am interested in...
    My interest is as a...